AIM:To expand the living donor liver transplantation(LT)pool of eligible patients with hepatocellular carcinoma(HCC)using new morphological and biological crite
Kidney transplantation is the best available treatment for patients with end stage renal disease.Despite the introduction of effective immunosuppressant drugs,e